VanEck Crypto and Blockchain Innovators UCITS ETF

The Product's investment objective is to replicate, before fees and expenses, the MVIS Global Digital Assets Equity Index (the "Index"). In order to seek to achieve its investment objective, the Manufacturer will use a replication strategy by investing directly in the underlying equity securities of the Index being the stocks, American depository receipts (ADRs), and global depository receipts (GDRs). Such equity securities must be issued by companies who generate at least 50% of their revenues /assets from the global digital assets segment, listed or traded on the Markets referred to in Appendix II of the Prospectus. For the avoidance of doubt, where the Index already holds such equity securities, the Index will seek to remove the security when the percentage of revenue generated from the global digital assets segment, drops below 25% of the relevant company's revenues. Where it is not practical or cost efficient for the Product to fully replicate the Index, the Manufacturer may utilise an optimised sampling methodology. Where it is not practical or cost efficient for the Product to fully replicate the Index, the Product will not avail of the increased limits as set out in Regulation 71 of the UCITS Regulations. The Product may invest up to 15% of its Net Asset Value directly in shares issued by companies listed on the Shanghai Stock Exchange or the Shenzhen Stock Exchange. The Product may invest more than 20% of its Net Asset Value in emerging markets. The Product may also (or alternatively) invest in financial derivative instruments (FDIs) which relate to the Index or constituents of the Index. The FDIs which the Product may use are futures, options (puts and calls), swaps (equity swaps and swaps on the Index), currency forwards and non deliverable forwards (a forward contract that does not require settlement on maturity) (NDFs). The Product invests in the underlying (physical) securities that make up the Index and does not take part in securities lending. T

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No